Beyond APHINITY: What Now After Pivotal Breast Cancer Trial? Beyond APHINITY: What Now After Pivotal Breast Cancer Trial?

Dr Kathy Miller speaks with APHINITY ' s principal investigator about whether survival in HER2+ disease can be pushed even further.Medscape Oncology

Source: Medscape Today Headlines - February 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news